Orange Book product · Brand (NDA)
ASTEPRO ALLERGY
AZELASTINE HYDROCHLORIDE
At a glance
Jun 17, 2021
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 17, 2021
5 yr 1 mo ago
Today
Patent 8071073 expires
Listed drug product patent expiration.
Jun 04, 2028
in 2 yr
Pharmaceutical detail
Active ingredient
AZELASTINE HYDROCHLORIDE
Strength
0.2055MG/SPRAY
Dosage form
SPRAY, METERED
Route
NASAL
TE code
Not listed
Application
NDA 213872
Product number
001
Marketing status
OTC
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2008ASTEPROBrand (NDA)
NDA 022203 · VIATRIS
- 2000OPTIVARBrand (NDA)
NDA 021127 · RISING
- 1996ASTELINBrand (NDA)
NDA 020114 · RISING
- 2025AZELASTINE HYDROCHLORIDE ALLERGYGeneric (ANDA)
ANDA 216561 · AUROBINDO PHARMA
- 2024AZELASTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216576 · AMNEAL
- 2024AZELASTINE HYDROCHLORIDE ALLERGYGeneric (ANDA)
ANDA 216421 · APOTEX
- 2024AZELASTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216801 · PADAGIS ISRAEL
- 2020AZELASTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212775 · AUROBINDO PHARMA LTD
- 2020AZELASTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212289 · AUROBINDO PHARMA LTD
- 2020AZELASTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210092 · GLAND
- 2019AZELASTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210032 · SCIEGEN PHARMS
- 2019AZELASTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 207610 · EPIC PHARMA LLC
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8071073 | Jun 04, 2028 | in 2 yr | Product |

